Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cangene's option to license Maxygen's MAXY-G34 for ARS expires

July 19, 2010

GTC regains rights to recombinant antithrombin ATryn

July 19, 2010

Galapagos and Bristol University to develop agents for diabetes-associated chronic pain

July 19, 2010

Elusys and Lonza extend contract to produce Anthim for inhalation anthrax

July 19, 2010

Biogen acquires rights to Amorfix's monoclonal antibodies for ALS

July 16, 2010

Cytos and A*STAR join to develop virus-like particle influenza vaccine

July 16, 2010

Invida to commercialize Amdipharm's products in Asia under new agreement

July 16, 2010

Aestus and Eisai to develop new therapeutics for psychiatric disorders

July 15, 2010

Silence Therapeutics and AstraZeneca extend siRNA development collaboration

July 15, 2010

HGS and Lonza form commercial manufacturing agreement for Benlysta

July 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...